Come up with a name for your new list and we'll add to it:
MediWound raised a round of funding on June 24, 2013. Investors include
Clal Biotechnology Industries.
MediWound is a biotechnology niche specialty company focused on developing, manufacturing and globally commercializing products that address unmet needs in the fields of severe burn and chronic wound …